Literature DB >> 21466562

Immunological mechanisms of allergen-specific immunotherapy.

Marek Jutel1, C A Akdis.   

Abstract

The studies on the mechanisms of specific immunotherapy (SIT) point out its targets that decide on the efficacy of SIT and hence might be used for its further improvement. Several mechanisms have been proposed to explain the beneficial effects of immunotherapy. The knowledge of the mechanisms underlying allergic diseases and curative treatment possibilities has experienced exciting advances over the last three decades. Studies in several clinical trials in allergen-SIT have demonstrated that the induction of a tolerant state against allergens in many ways represents a key step in the development of a healthy immune response against allergens. Several cellular and molecular mechanisms have been demonstrated: allergen-specific suppressive capacities of both inducible subsets of CD4(+) CD25(+) forkhead box P3(+) T-regulatory and IL-10-secreting type 1 T-regulatory cells increase in peripheral blood; suppression of eosinophils, mast cells, and basophils; Ab isotype change from IgE to IgG4. This review aims at the better understanding of the observed immunological changes associated with allergen SIT.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21466562     DOI: 10.1111/j.1398-9995.2011.02589.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  62 in total

Review 1.  Treating human autoimmunity: current practice and future prospects.

Authors:  Michael D Rosenblum; Iris K Gratz; Jonathan S Paw; Abul K Abbas
Journal:  Sci Transl Med       Date:  2012-03-14       Impact factor: 17.956

2.  Design of a ProDer f 1 vaccine delivered by the MHC class II pathway of antigen presentation and analysis of the effectiveness for specific immunotherapy.

Authors:  Zhiming Liu; Yuxin Jiang; Chaopin Li
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

Review 3.  Venom immunotherapy: an updated review.

Authors:  Darío Antolín-Amérigo; Carmen Moreno Aguilar; Arantza Vega; Melchor Alvarez-Mon
Journal:  Curr Allergy Asthma Rep       Date:  2014-07       Impact factor: 4.806

4.  2-Hydroxy-3-methoxybenzoic acid attenuates mast cell-mediated allergic reaction in mice via modulation of the FcεRI signaling pathway.

Authors:  Yeon-Yong Kim; In-Gyu Je; Min Jong Kim; Byeong-Cheol Kang; Young-Ae Choi; Moon-Chang Baek; Byungheon Lee; Jin Kyeong Choi; Hae Ran Park; Tae-Yong Shin; Soyoung Lee; Seung-Bin Yoon; Sang-Rae Lee; Dongwoo Khang; Sang-Hyun Kim
Journal:  Acta Pharmacol Sin       Date:  2016-11-28       Impact factor: 6.150

Review 5.  Utility and Comparative Efficacy of Recombinant Allergens Versus Allergen Extract.

Authors:  Hardik D Patel; Jeffrey M Chambliss; Meera R Gupta
Journal:  Curr Allergy Asthma Rep       Date:  2017-08-18       Impact factor: 4.806

Review 6.  [Specific immunotherapy and atopic dermatitis. What is new?].

Authors:  N Novak; T Werfel
Journal:  Hautarzt       Date:  2011-09       Impact factor: 0.751

Review 7.  Decorating and loading ghosts with allergens for allergen immunotherapy.

Authors:  Songwe Fanuel; Saeideh Tabesh; Huda Fatima Rajani; Sahel Heidari; Esmaeil Sadroddiny; Gholam Ali Kardar
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

8.  Adjuvant effects of aluminium hydroxide-adsorbed allergens and allergoids - differences in vivo and in vitro.

Authors:  B Heydenreich; I Bellinghausen; L Lund; H Henmar; G Lund; P Adler Würtzen; J Saloga
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

Review 9.  Recombinant allergens: the present and the future.

Authors:  Marek Jutel; Katarzyna Solarewicz-Madejek; Sylwia Smolinska
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

Review 10.  Specific immunotherapy in grass pollen allergy.

Authors:  Claire Mailhol; Alain Didier
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.